Pharmacokinetics of tocolytic agents

Area of Science:

• Pharmacology and Obstetrics
• Maternal-Fetal Medicine

Background:

• Tocolytic agents inhibit myometrial smooth muscle contractions.
• Available agents include beta-adrenergic agonists, calcium channel antagonists, oxytocin antagonists, NSAIDs, and magnesium sulfate.
• The primary goal of tocolysis is to prevent preterm birth complications, not just delay delivery.

Purpose of the Study:

• To review pharmacological data on drugs used for preterm labor.
• To inform optimal drug dosage and administration routes in pregnant women.
• To highlight the importance of considering altered pharmacokinetics during pregnancy.

Main Methods:

• Review of pharmacological data for current tocolytic agents.
• Analysis of pharmacokinetic alterations during pregnancy.
• Discussion of maternal and fetal toxicity considerations.

Main Results:

• Pregnancy significantly alters drug pharmacokinetics: absorption, distribution, metabolism, and excretion.
• These changes often lead to reduced plasma drug concentrations and shorter half-lives.
• The effectiveness of tocolytics in reducing perinatal morbidity/mortality remains unclear.

Conclusions:

• Tocolytic use in preterm labor is complex and potentially controversial.
• Understanding pregnancy-induced pharmacokinetic changes is crucial for safe and effective drug use.
• Further research is needed to confirm the benefits of tocolytics in reducing perinatal complications.